Dr. Novack Lectures on Ophthalmic Drug Development at SNEC and SERI

Singapore, November 2025
Dr. Novack gave a lecture on “Ophthalmic Drug Development” at the Singapore National Eye Centre (SNEC) / Singapore Eye Research Institute (SERI).  Dr. Novack has a decades long relationship with SNEC and SERI, going back to work on myopia prevention in the early 2000’s. 

(Above) Dr. Novack delivering a lecture on ophthalmic drug development at the Singapore National Eye Centre and Singapore Eye Research Institute, continuing a decades-long collaboration that began with early work in myopia prevention.

About Dr. Novack

Dr. Gary Novack is a board-certified clinical pharmacologist and President of PharmaLogic Development with more than 40 years of experience in ophthalmic drug development, clinical research, and FDA regulatory strategy.

He has consulted for over 100 pharmaceutical and medical device companies and authored more than 400 scientific publications.

Contact Dr. Novack
Contact Dr. Novack